Cover ImageSALE
市場調查報告書

ED (勃起功能障礙) 治療的全球市場:2016∼2020年

Global Erectile Dysfunction Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 373444
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
ED (勃起功能障礙) 治療的全球市場:2016∼2020年 Global Erectile Dysfunction Market 2016-2020
出版日期: 2016年09月28日 內容資訊: 英文 70 Pages
簡介

喪失勃起能力的各種原因,包含高血壓,老齡化,糖尿病,抽煙,酒精中毒,憂鬱症,神經、脊髓損傷,睪固酮水準低等要素。另一方面,ED治療用各種藥物和植入也上市了。全球ED治療市場預計今後 (2016∼2020年) 將緩慢成長,2020年達到40億8000萬美元的規模。

本報告提供全球ED (勃起功能障礙) 市場相關分析,疾病概要和市場基本結構,市場規模趨勢 (今後5年的預測值),各產品 (治療藥、設備) 及各地區詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 定義
  • 供應商的明細
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 各產品的市場區隔

  • 全球ED治療市場:各產品的明細 (治療藥、治療設備)

第7章 市場區隔:ED治療藥的各類型

第8章 市場區隔:ED治療設備的各類型

第9章 地區區分

  • 全球ED治療市場:各地區
  • 南北美洲市場
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 亞太地區市場

第10章 推動市場要素

第11章 推動因素的影響力

第12章 市場課題

第13章 推動因素、課題的影響力

第14章 市場趨勢

第15章 供應商環境

  • 競爭方案

第16章 主要供應商分析

  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer
  • 其他卓越供應商

第17章 附錄

  • 簡稱集

第18章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR9506

About Erectile Dysfunction

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

Technavio's analysts forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer

Other Prominent Vendors

  • Apricus Biosciences
  • Cristalia Produtos Quimicos Farmaceuticos
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Futura Medical
  • Meda Pharmaceuticals
  • Promedon
  • SK Chemical
  • Teva Pharmaceuticals
  • Vivus
  • Zephyr Surgical Implants (ZSI)

Market driver

  • Demand from older adult male population
  • For a full, detailed list, view our report

Market challenge

  • Threat of counterfeit products
  • For a full, detailed list, view our report

Market trend

  • Migration of manufacturing and sales facilities to APAC
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Definition
  • Vendor segmentation
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global ED treatment market by product
  • Global ED drugs market
  • Global ED devices market

PART 07: Market segmentation by type of ED drugs

  • Global ED treatment market by type of ED drugs

PART 08: Market segmentation by type of ED device

  • Global ED treatment market by type of ED device

PART 09: Geographical segmentation

  • Global ED treatment market by geography
  • ED treatment market in Americas
  • ED treatment market in EMEA
  • ED treatment market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Key vendor analysis

  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Global erectile dysfunction treatment market by product
  • Exhibit 02: Key countries
  • Exhibit 03: Product offerings
  • Exhibit 04: Major causes of ED
  • Exhibit 05: Global ED treatment market 2015-2020 ($ billions)
  • Exhibit 06: Key drug patent expirations in major countries
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Global ED treatment market by product 2015 and 2020
  • Exhibit 09: Global ED treatment market by product 2015-2020
  • Exhibit 10: Global ED drugs market 2015-2020 ($ billions)
  • Exhibit 11: Global ED devices market 2015-2020 ($ millions)
  • Exhibit 12: ED device market by geography 2015 and 2020
  • Exhibit 13: Global ED treatment market by type of ED drugs 2015
  • Exhibit 14: Global ED treatment market by type of ED device 2015 and 2020
  • Exhibit 15: Global ED treatment market by geography 2015 and 2020
  • Exhibit 16: Global ED treatment market by geography 2015-2020 ($ millions)
  • Exhibit 17: ED treatment market in Americas 2015-2020 ($ billions)
  • Exhibit 18: ED treatment market in Americas by drugs and devices
  • Exhibit 19: ED treatment market in EMEA 2015-2020 ($ billions)
  • Exhibit 20: Occurrence of ED by age 2015
  • Exhibit 21: ED treatment market in EMEA by drugs and devices 2015 and 2020
  • Exhibit 22: ED treatment market in APAC 2015-2020 ($ millions)
  • Exhibit 23: ED treatment market in APAC by drugs and devices 2015 and 2020
  • Exhibit 24: ED treatment Market by product across regions 2015 and 2020 ($ million)
  • Exhibit 25: Estimated cancer cases and deaths in US 2016 (thousands)
  • Exhibit 26: Chances of men developing ED by age in the US
  • Exhibit 27: Number of individuals with diabetes around the world 2015 and 2040 (millions)
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Impact of drivers and challenges
  • Exhibit 30: Bayer: Key takeaways
  • Exhibit 31: Boston Scientific: Key takeaways
  • Exhibit 32: Coloplast: Key takeaways
  • Exhibit 33: Eli Lilly: Key takeaways
  • Exhibit 34: Pfizer: Key takeaways
Back to Top